Aptose Biosciences Inc. (TSE:APS – Get Free Report) (NASDAQ:APTO) passed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of C$1.71 and traded as high as C$2.13. Aptose Biosciences shares last traded at C$1.98, with a volume of 2,759 shares trading hands.
Aptose Biosciences Price Performance
The company has a current ratio of 1.05, a quick ratio of 5.41 and a debt-to-equity ratio of -117.37. The company has a market capitalization of C$4.80 million, a price-to-earnings ratio of -0.24 and a beta of -0.05. The company has a 50 day moving average price of C$1.71 and a 200 day moving average price of C$1.94.
About Aptose Biosciences
Aptose Biosciences Inc, a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in Canada. Its lead clinical program is APTO-253, which is a Phase I clinical trial for the treatment of patients with relapsed or refractory hematologic malignancies.
Recommended Stories
- Five stocks we like better than Aptose Biosciences
- 5 discounted opportunities for dividend growth investors
- Rivian’s Chart Says Go, But Some Analysts Still Say No
- What Are Dividends? Buy the Best Dividend Stocks
- e.l.f. Sell-Off Is a Good Time to Buy, According to Analysts
- The Basics of Support and Resistance
- T-Mobile Is The Most Oversold Mega-Cap Stock—Time to Buy?
Receive News & Ratings for Aptose Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aptose Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
